JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

Search

Hologic Inc

Закрыт

СекторЗдравоохранение

73.91 -0.07

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

73.85

Макс.

74.04

Ключевые показатели

By Trading Economics

Доход

212M

195M

Продажи

19M

1B

P/E

Средняя по отрасли

30.685

37.003

Прибыль на акцию

1.08

Рентабельность продаж

19.037

Сотрудники

7,063

EBITDA

341M

334M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+5.43% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

3 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.8B

16B

Предыдущая цена открытия

73.98

Предыдущая цена закрытия

73.91

Новостные настроения

By Acuity

28%

72%

65 / 373 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Hologic Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

21 окт. 2025 г., 13:20 UTC

Приобретения, слияния, поглощения

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

27 мая 2025 г., 18:46 UTC

Главные движущие силы рынка
Приобретения, слияния, поглощения

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

21 окт. 2025 г., 16:36 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Hologic Seen as Prime Take-Private Candidate -- Market Talk

21 окт. 2025 г., 13:05 UTC

Приобретения, слияния, поглощения

Blackstone, TPG to Buy Hologic for Up to $18.3B

21 окт. 2025 г., 12:50 UTC

Приобретения, слияния, поглощения

Hologic Plans to File Form 10-K for Fiscal 2025 With the SEC in Late Nov >HOLX

21 окт. 2025 г., 12:49 UTC

Приобретения, слияния, поглощения

Hologic Does Not Intend to Provide Fincl Guidance for FY26 in Upcoming 4Q Results Release

21 окт. 2025 г., 12:48 UTC

Приобретения, слияния, поглощения

Hologic Merger Agreement Includes a 45-Day 'Go-Shop' Period >HOLX

21 окт. 2025 г., 12:48 UTC

Приобретения, слияния, поглощения

Hologic Will Continue to Operate Under the Hologic Name and Brand >HOLX

21 окт. 2025 г., 12:48 UTC

Приобретения, слияния, поглощения

Hologic Will Maintain Its Headquarters in Marlborough, Massachusetts >HOLX

21 окт. 2025 г., 12:47 UTC

Приобретения, слияния, поглощения

Blackstone's Private Equity Strategy for Individual Investors Is Also Expected to Invest as Part of Transaction

21 окт. 2025 г., 12:46 UTC

Приобретения, слияния, поглощения

Blackstone and TPG Secured Committed Financing From Citi, Bank of Amer, Barclays, Royal Bank of Canada and SMBC

21 окт. 2025 г., 12:46 UTC

Приобретения, слияния, поглощения

Blackstone and TPG Have Secured Committed Financing for the Transaction >HOLX

21 окт. 2025 г., 12:45 UTC

Приобретения, слияния, поглощения

Hologic: Transaction Includes Significant Minority Investments From Subsidiary of Abu Dhabi Investment Authority and an Affil of GIC >HOLX

21 окт. 2025 г., 12:45 UTC

Приобретения, слияния, поглощения

Hologic: Purchase Price Represents Premium of About 46% to Closing Price on May 23 >HOLX

21 окт. 2025 г., 12:45 UTC

Приобретения, слияния, поглощения

Hologic: Non-tradable CVR Would Be Issued to Holders at Closing and Paid Following Achievement of Certain Global Rev Goals for Breast Health Business in FY26, FY27

21 окт. 2025 г., 12:44 UTC

Приобретения, слияния, поглощения

Blackstone and TPG Will Acquire Hologic Shrs for $76/Shr in Cash Plus Non-Tradable CVR to Get Up to $3/Shr for Total of Up to $79/Shr in Cash >HOLX

21 окт. 2025 г., 12:42 UTC

Приобретения, слияния, поглощения

Hologic: Transaction Will Help Strengthen Leadership in Women's Health and Accelerate Growth >HOLX

21 окт. 2025 г., 12:42 UTC

Приобретения, слияния, поглощения

Hologic to Be Acquired by Funds Managed by Blackstone Deal and TPG in Deal With Enterprise Value of Up to $18.3 B >BX HOLX

27 мая 2025 г., 20:07 UTC

Приобретения, слияния, поглощения

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 мая 2025 г., 19:06 UTC

Приобретения, слияния, поглощения

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 мая 2025 г., 18:26 UTC

Приобретения, слияния, поглощения

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Hologic Inc Прогноз

Целевая цена

By TipRanks

5.43% рост

Прогноз на 12 месяцев

Средняя 78 USD  5.43%

Максимум 94 USD

Минимум 69 USD

Основано на мнении 13 аналитиков Wall Street, спрогнозировавших целевые цены для Hologic Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

13 ratings

3

Покупка

10

Удержание

0

Продажа

Техническая оценка

By Trading Central

52.69 / 58.605Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Weak Bearish Evidence

Долгосрочная

Bearish Evidence

Настроения

By Acuity

65 / 373Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
help-icon Live chat